Suppr超能文献

靶向肝素和硫酸乙酰肝素蛋白相互作用。

Targeting heparin and heparan sulfate protein interactions.

作者信息

Weiss Ryan J, Esko Jeffrey D, Tor Yitzhak

机构信息

Department of Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California, San Diego, La Jolla, CA 92093-0358, USA.

Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, CA 92093-0358, USA.

出版信息

Org Biomol Chem. 2017 Jul 21;15(27):5656-5668. doi: 10.1039/c7ob01058c. Epub 2017 Jun 27.

Abstract

Heparin and heparan sulfate glycosaminoglycans are long, linear polysaccharides that are made up of alternating dissacharide sequences of sulfated uronic acid and amino sugars. Unlike heparin, which is only found in mast cells, heparan sulfate is ubiquitously expressed on the cell surface and in the extracellular matrix of all animal cells. These negatively-charged glycans play essential roles in important cellular functions such as cell growth, adhesion, angiogenesis, and blood coagulation. These biomolecules are also involved in pathophysiological conditions such as pathogen infection and human disease. This review discusses past and current methods for targeting these complex biomolecules as a novel therapeutic strategy to treating disorders such as cancer, neurodegenerative diseases, and infection.

摘要

肝素和硫酸乙酰肝素糖胺聚糖是长链线性多糖,由硫酸化糖醛酸和氨基糖的交替二糖序列组成。与仅存在于肥大细胞中的肝素不同,硫酸乙酰肝素在所有动物细胞的细胞表面和细胞外基质中普遍表达。这些带负电荷的聚糖在细胞生长、黏附、血管生成和血液凝固等重要细胞功能中发挥着关键作用。这些生物分子还参与病原体感染和人类疾病等病理生理状况。本综述讨论了过去和当前针对这些复杂生物分子的方法,将其作为治疗癌症、神经退行性疾病和感染等疾病的一种新型治疗策略。

相似文献

1
Targeting heparin and heparan sulfate protein interactions.
Org Biomol Chem. 2017 Jul 21;15(27):5656-5668. doi: 10.1039/c7ob01058c. Epub 2017 Jun 27.
3
Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer.
Matrix Biol. 2010 Jul;29(6):442-52. doi: 10.1016/j.matbio.2010.04.003. Epub 2010 Apr 21.
4
Heparin-protein interactions.
Angew Chem Int Ed Engl. 2002 Feb 1;41(3):391-412. doi: 10.1002/1521-3773(20020201)41:3<390::aid-anie390>3.0.co;2-b.
5
Heparin and heparan sulfate: biosynthesis, structure and function.
Curr Opin Chem Biol. 2000 Dec;4(6):626-31. doi: 10.1016/s1367-5931(00)00145-9.
6
Bioengineered heparins and heparan sulfates.
Adv Drug Deliv Rev. 2016 Feb 1;97:237-49. doi: 10.1016/j.addr.2015.11.002. Epub 2015 Nov 10.
7
Glycosaminoglycan Analysis: Purification, Structural Profiling, and GAG-Protein Interactions.
Methods Mol Biol. 2023;2597:159-176. doi: 10.1007/978-1-0716-2835-5_13.
8
Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches.
Glycobiology. 2004 Apr;14(4):17R-30R. doi: 10.1093/glycob/cwh051. Epub 2004 Jan 12.
9
Glycosaminoglycans in Neurodegenerative Diseases.
Adv Exp Med Biol. 2021;1325:189-204. doi: 10.1007/978-3-030-70115-4_9.
10
Glycosaminoglycan Neutralization in Coagulation Control.
Arterioscler Thromb Vasc Biol. 2018 Jun;38(6):1258-1270. doi: 10.1161/ATVBAHA.118.311102. Epub 2018 Apr 19.

引用本文的文献

5
Expanding the Role of Heparin Derivatives in Oncology: From Anticoagulation to Antitumor Activity.
Pharmaceuticals (Basel). 2025 Mar 12;18(3):396. doi: 10.3390/ph18030396.
6
SARS-CoV-2 infectivity can be modulated through bacterial grooming of the glycocalyx.
mBio. 2025 Apr 9;16(4):e0401524. doi: 10.1128/mbio.04015-24. Epub 2025 Feb 25.
7
Over-the-counter carrageenan-based sprays may interfere with PCR testing of nasopharyngeal swabs to detect SARS-CoV-2.
PLoS One. 2025 Feb 6;20(2):e0316700. doi: 10.1371/journal.pone.0316700. eCollection 2025.
9
Time-course remodeling and pathology intervention of α-synuclein amyloid fibril by heparin and heparin-like oligosaccharides.
Nat Struct Mol Biol. 2025 Feb;32(2):369-380. doi: 10.1038/s41594-024-01407-2. Epub 2024 Oct 17.
10

本文引用的文献

1
Small molecule antagonists of cell-surface heparan sulfate and heparin-protein interactions.
Chem Sci. 2015 Oct 1;6(10):5984-5993. doi: 10.1039/c5sc01208b. Epub 2015 Jul 29.
2
Construction and characterisation of a heparan sulphate heptasaccharide microarray.
Chem Commun (Camb). 2017 Jan 31;53(10):1743-1746. doi: 10.1039/c6cc08204a.
3
Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA.
Blood. 2017 Mar 9;129(10):1368-1379. doi: 10.1182/blood-2016-10-747915. Epub 2016 Dec 29.
4
Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparin.
Thromb Res. 2016 Oct;146:113-118. doi: 10.1016/j.thromres.2016.07.008. Epub 2016 Jul 18.
5
The toxicology of heparin reversal with protamine: past, present and future.
Expert Opin Drug Metab Toxicol. 2016 Aug;12(8):897-909. doi: 10.1080/17425255.2016.1194395. Epub 2016 Jun 6.
6
Reversal agents for use with direct and indirect anticoagulants.
Am J Health Syst Pharm. 2016 May 15;73(10 Suppl 2):S27-48. doi: 10.2146/ajhp150959.
7
De Novo Sequencing of Complex Mixtures of Heparan Sulfate Oligosaccharides.
Anal Chem. 2016 May 17;88(10):5299-307. doi: 10.1021/acs.analchem.6b00519. Epub 2016 Apr 27.
8
Expanding the 3-O-Sulfate Proteome--Enhanced Binding of Neuropilin-1 to 3-O-Sulfated Heparan Sulfate Modulates Its Activity.
ACS Chem Biol. 2016 Apr 15;11(4):971-80. doi: 10.1021/acschembio.5b00897. Epub 2016 Jan 14.
9
The sweet spot: how GAGs help chemokines guide migrating cells.
J Leukoc Biol. 2016 Jun;99(6):935-53. doi: 10.1189/jlb.3MR0915-440R. Epub 2015 Dec 23.
10
The Cholestanol-Conjugated Sulfated Oligosaccharide PG545 Disrupts the Lipid Envelope of Herpes Simplex Virus Particles.
Antimicrob Agents Chemother. 2015 Dec 7;60(2):1049-57. doi: 10.1128/AAC.02132-15. Print 2016 Feb.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验